- HK$820.80bn
- HK$666.09bn
- CNY416.61bn
- 97
- 86
- 82
- 100
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 233,199 | 155,372 | 246,111 | 422,230 | 416,609 |
Cost of Revenue | |||||
Gross Profit | 179,424 | 119,461 | 201,485 | 333,281 | 307,857 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 149,004 | 118,983 | 150,132 | 228,905 | 248,840 |
Operating Profit | 84,195 | 36,389 | 95,979 | 193,325 | 167,769 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 85,649 | 34,907 | 95,821 | 194,770 | 172,974 |
Provision for Income Taxes | |||||
Net Income After Taxes | 61,045 | 24,956 | 70,307 | 141,677 | 124,090 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 61,045 | 24,956 | 70,320 | 141,700 | 123,843 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 61,045 | 24,956 | 70,320 | 141,700 | 123,843 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.4 | 0.664 | 1.71 | 3.05 | 2.66 |
Dividends per Share | |||||
Special Dividends per Share |